IRIS
GENTILE, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.283
NA - Nord America 3.749
AS - Asia 2.411
SA - Sud America 668
Continente sconosciuto - Info sul continente non disponibili 336
AF - Africa 69
Totale 11.516
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.626
RU - Federazione Russa 2.108
SG - Singapore 1.034
CN - Cina 619
IT - Italia 558
BR - Brasile 553
IE - Irlanda 486
HK - Hong Kong 298
SE - Svezia 283
DE - Germania 203
FR - Francia 144
PL - Polonia 142
FI - Finlandia 138
VN - Vietnam 134
IN - India 99
GB - Regno Unito 80
BD - Bangladesh 59
CA - Canada 54
AR - Argentina 44
MX - Messico 36
AT - Austria 27
NL - Olanda 26
TR - Turchia 26
ID - Indonesia 24
EC - Ecuador 22
JP - Giappone 20
BE - Belgio 19
MA - Marocco 16
ZA - Sudafrica 16
UA - Ucraina 15
PK - Pakistan 14
VE - Venezuela 13
UZ - Uzbekistan 12
ES - Italia 11
CI - Costa d'Avorio 10
CO - Colombia 10
IQ - Iraq 9
CR - Costa Rica 8
LT - Lituania 8
MY - Malesia 8
PE - Perù 8
TN - Tunisia 8
AZ - Azerbaigian 7
CL - Cile 7
KE - Kenya 7
PH - Filippine 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
NP - Nepal 6
RO - Romania 6
PY - Paraguay 5
HN - Honduras 4
NI - Nicaragua 4
SA - Arabia Saudita 4
BO - Bolivia 3
CH - Svizzera 3
DO - Repubblica Dominicana 3
EU - Europa 3
GR - Grecia 3
GT - Guatemala 3
JM - Giamaica 3
KH - Cambogia 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
SK - Slovacchia (Repubblica Slovacca) 3
UY - Uruguay 3
AL - Albania 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SN - Senegal 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
DK - Danimarca 1
EG - Egitto 1
GD - Grenada 1
GN - Guinea 1
IL - Israele 1
IR - Iran 1
JO - Giordania 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LU - Lussemburgo 1
MN - Mongolia 1
PA - Panama 1
PR - Porto Rico 1
Totale 11.181
Salva come PNG Salva come JPEG
Città #
Ashburn 803
Moscow 673
Singapore 546
Dublin 482
Dallas 385
Chandler 320
Hong Kong 294
San Jose 223
Nyköping 214
Beijing 203
Messina 193
Council Bluffs 144
Warsaw 138
Munich 133
The Dalles 111
Los Angeles 81
Lauterbourg 75
Princeton 72
Helsinki 70
Medford 63
Ann Arbor 50
Des Moines 49
New York 43
Buffalo 42
Ho Chi Minh City 41
São Paulo 38
Jacksonville 37
Santa Clara 37
Tianjin 36
Pune 30
Turku 30
Wilmington 29
Bremen 24
Dearborn 24
Orem 23
Palermo 22
Redondo Beach 22
Lappeenranta 21
Rome 21
Seattle 21
Chennai 20
Hyderabad 20
Belo Horizonte 19
Brooklyn 19
Cambridge 19
Guangzhou 19
London 19
Chicago 18
Hanoi 18
Nuremberg 18
Rio de Janeiro 17
Houston 16
Jinan 16
Milan 16
San Francisco 16
Tokyo 16
Boardman 15
Brussels 15
Columbus 15
Frankfurt am Main 15
Phoenix 15
Atlanta 14
Redwood City 14
Vienna 14
Curitiba 13
Shanghai 13
Boston 12
Brasília 12
Duncan 12
Falls Church 12
Mexico City 12
Tashkent 12
Amsterdam 11
Denver 11
Montreal 11
Abidjan 10
Catania 10
Guayaquil 10
Jakarta 10
Porto Alegre 10
Toronto 10
Zhengzhou 10
Poplar 9
Campinas 8
Changsha 8
Dong Ket 8
Johannesburg 8
Ningbo 8
San José 8
Shenyang 8
Shenzhen 8
Baku 7
Da Nang 7
Istanbul 7
Livorno 7
Manaus 7
Nanjing 7
Quito 7
San Mateo 7
Taizhou 7
Totale 6.603
Salva come PNG Salva come JPEG
Nome #
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 369
HATTR italian registry: preliminary data from the collaborative network of telethon GUP 15010 study 342
6MWT performance correlates with peripheral neuropathy but not with cardiac involvement in patients with hereditary transthyretin amyloidosis (hATTR) 336
Diagnostic utility of Sudoscan for detecting Bortezomib-induced painful neuropathy 257
A Nouvel serum MicroRNA signature to screen ATTR 233
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area 216
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
Transthyretin-Related Familial Amyloid Polyneuropathy (TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 198
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 192
Chronic inflammatory demyelinating polyradiculoneuropathy: can a diagnosis be made in patients not fulfilling electrodiagnostic criteria? 180
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 178
Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 176
Charcot-Marie-Tooth 2F: phenotypic presentation of the Arg136Leu HSP27 mutation in a multigenerational family 173
Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study 172
Genetic neuromuscular disorders: living the era of a therapeutic revolution. Part 1: peripheral neuropathies 171
Cardiac 99mTc-DPD uptake in subjects with Glu89Gln transthyretin gene mutation: is it the earliest sign of disease development? 170
Anxiety and depression in Charcot-Marie-Tooth disease: data from the Italian CMT national registry 157
Predicting needlestick and sharps injuries in nursing students: Development of the SNNIP scale 156
Prevalence and diagnostic value of extra-left ventricle echocardiographic findings in transthyretin-related cardiac amyloidosis 155
Novel outcome measures for Charcot-Marie-Tooth disease: Validation and reliability of the 6-min walk test and StepWatch™ Activity Monitor and identification of the walking features related to higher quality of life 154
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 151
Clinical and genotype characteristics and symptom migration in patients with mixed phenotype transthyretin amyloidosis from the transthyretin amyloidosis outcomes survey 146
Unilateral hyperhidrosis as persistently isolated feature of syringomyelia and Arnold Chiari type 1 136
A multicentre study on epidemiology and prevention of needle stick injuries among students of nursing schools 132
Monitoring safety and effectiveness of tafamidis in transthyretin amyloidosis in italy. A 3-year longitudinal multicenter study in a non-endemic area. 131
CMT subtypes in a cohort of italian patients enrolled at Messina neuromuscular centre since 1994 to 2014. 131
A Cyst Compressing the Ulnar Nerve Motor Branch: Ultrasonographic Diagnosis of a Tricking Neuropathy. 130
Considerable post-partum worsening in a patient with CMT2E 129
Phenotypic variability of TTR Val122Ile mutation: a Caucasian patient with axonal neuropathy and normal heart 127
Serial scanning with 99mTc-3, 3-diphosphono-1, 2-propanodicarboxylic acid (99mTc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation 127
Use of the International Classification of Functioning, Disability and Health Generic-30 Set for the characterization of outpatients: Italian Society of physical and rehabilitative medicine residents section project 125
"It is not what it seems." Ultrasound findings in a case of unusual iatrogenic ulnar nerve damage. 123
A multicentric study of the disease risks and first manifestations in Hereditary transthyretin amyloidosis (ATTRv): insights for an earlier diagnosis 120
Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database 120
Patients' and physicians' interpretation of chemotherapy-induced peripheral neurotoxicity 118
Clinical spectrum and frequency of Charcot-Marie-Tooth disease in Italy: data from the national CMT registry 117
Diagnostic utility of Sudoscan for detecting bortezomib-induced painful neuropathy: a study on 18 patients with multiple myeloma 117
Neurological data collection protocol on tafamidis meglumine treatment for familial amyloid polyneuropathy: preliminary data on patients enrolled by the italian network 117
Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: neurological and cardiological features 117
Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9) 116
"Seeing Through the Wall": Ultrasound Application for the Diagnosis and Treatment of Abdominal Pain. 116
"Who seeks finds, who compares discovers". Usefulness of ultrasound to assess small nerve branches. 115
A 15-year consolidated overview of data in over 6000 patients from the Transthyretin Amyloidosis Outcomes Survey (THAOS) 112
Efficacy and quality of life in patients with multifocal motor neuropathy treated by subcutaneous immunoglobulin. 108
Nerve ultrasound in hereditary transthyretin amyloidosis: red flags and possible progression biomarkers 108
Psychosocial burden and professional and social support in patients with hereditary transthyretin amyloidosis (ATTRv) and their relatives in Italy 108
Subcutaneous immunoglobulin in CIDP and MMN: a different long-term clinical response? 107
Safety and tolerability of orally administered tafamidis meglumine in TTR FAP: preliminary data at 3-month follow-up 107
Correction to: Diagnosis of cardiac amyloid transthyretin (ATTR) amyloidosis by early (soft tissue) phase [99mTc]Tc-DPD whole body scan: comparison with late (bone) phase imaging 105
Relevance of diagnostic investigations in chronic inflammatory demyelinating poliradiculoneuropathy: data from the Italian CIDP database 104
Very Early Onset of ATTRE89Q Amyloidosis in a Homozygous Patient 103
HATTR : Neurotrophic factors expression in schwann cell line after MIR-150 transfection. 100
Early detection of cardiac amyloid deposition in subjects with transthyretin gene mutation by 99mTc-disphosphonate scintigraphy 98
Impact of environmental factors and physical activity on disability and quality of life in CIDP 98
The THAOS: record of patients from our site. 96
Frequency of diabetes and other comorbidities in chronic inflammatory demyelinating polyradiculoneuropathy and their impact on clinical presentation and response to therapy 96
Long-term treatment of hereditary transthyretin amyloidosis with patisiran: multicentre, real-world experience in Italy 94
Quantitative comparison between amyloid deposition detected by 99mTc-diphosphonate imaging and myocardial deformation evaluated by strain echocardiography in transthyretin related cardiac amyloidosis 94
From a misdiagnosis of anorexia nervosa to a dramatic patisiran-induced improvement in a patient with ATTRE89Q amyloidosis 94
hATTR Pathology: Nerve Biopsy Results from Italian Referral Centers 94
Patisiran treatment in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy after liver transplantation 92
TRPA1 rare variants in chronic neuropathic and nociplastic pain patients 90
Early detection of cardiac amyloid deposition in patients with transthyretin-related familial amyloid polyneuropathy by 99mTc-diphosphonate scintigraphy 90
Long-term treatment with subcutaneous immunoglobulin in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a follow-up period up to 7 years 90
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 90
Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the transthyretin amyloidosis outcomes survey (THAOS) 89
Phenotypic spectrum of myelin protein zero-related neuropathies: a large cohort study from five mutation clusters across Italy 88
Transthyretin-related familial amyloidotic polyneuropathy: description of a cohort of patients with Leu64 mutation and late onset. 88
Patisiran in hATTR Amyloidosis: Six-Month Latency Period before Efficacy 87
Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy 84
Long-term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: NEURO-TTR open-label extension 3-year update 84
Unclassified clinical presentations of chronic inflammatory demyelinating polyradiculoneuropathy 83
Long-term treatment with subcutaneous immunoglobulin in multifocal motor neuropathy 82
Use of drugs for ATTRv amyloidosis in the real world: How therapy is changing survival in a non-endemic area 82
Comparison of the diagnostic accuracy of the 2021 EAN/PNS and 2010 EFNS/PNS diagnostic criteria for chronic inflammatory demyelinating polyradiculoneuropathy 81
(TTR-FAP): A Single-Center Experience in Sicily, an Italian Endemic Area 81
Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants 79
Real-life experience with inotersen in hereditary transthyretin amyloidosis with late-onset phenotype: data from an early-access program in Italy 79
Ultrasound guidance increases diagnostic yield of needle EMG in plegic muscle. 72
Progressive brachial plexus enlargement in hereditary transthyretin amyloidosis 70
Prolonged distal motor latency of median nerve does not improve diagnostic accuracy for CIDP 70
Rare among rare: Phenotypes of uncommon CMT genotypes 69
Use of Drugs for ATTRv Amyloidosis in the Real World: How Therapy Is Changing Survival in a Non-Endemic Area 65
Shear wave elastography of median nerve at wrist and forearm. Heterogeneity of normative values. 61
Phenotypic Differences of Glu89Gln Genotype in ATTR Amyloidosis From Endemic Loci: Update From THAOS 60
null 54
Frequency, entity and determinants of fatigue in Charcot-Marie-Tooth disease 48
Italian Real-Life Experience of Patients with Hereditary Transthyretin Amyloidosis Treated with Patisiran 47
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy 41
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 34
Serum neurofilament light chain: a promising early diagnostic biomarker for hereditary transthyretin amyloidosis? 33
Daytime sleepiness and sleep quality in Charcot-Marie-Tooth disease 30
null 30
Use, tolerability, benefits and side effects of orthotic devices in Charcot-Marie-Tooth disease 30
Machine Learning for Early Diagnosis of ATTRv Amyloidosis in Non-Endemic Areas: A Multicenter Study from Italy 29
Neuropathic pain experience in symptomatic and presymptomatic subjects carrying a transthyretin gene mutation 27
Patisiran in ATTRv amyloidosis with polyneuropathy: "PatisiranItaly" multicenter observational study 23
Phenotype-Genotype Correlations in Early-Onset Myelin Protein Zero–Related Neuropathies 23
The neurophysiological lesson from the Italian CIDP database 23
Totale 11.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.054
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.054
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022454 0 47 3 16 39 11 47 28 16 22 31 194
2022/20231.267 105 115 77 76 86 114 18 61 562 13 25 15
2023/2024392 27 54 21 27 32 107 16 32 5 25 6 40
2024/20252.205 72 22 48 141 137 141 202 312 441 124 212 353
2025/20265.801 321 462 434 357 478 1.147 682 699 642 299 129 151
2026/2027448 221 227 0 0 0 0 0 0 0 0 0 0
Totale 11.516